Agomelatine 25mgTablet
Anti-Depressant & Anxiety

Agomelatine 25mg

Agomelatine

Novel antidepressant with dual melatonergic MT1/MT2 agonist and 5-HT2C antagonist mechanism, restoring circadian rhythm disruption underlying depression while improving sleep architecture without sedation or sexual dysfunction. Manufactured by Sun Pharma and Intas for export to psychiatric markets globally.

Strengths

25mg

Packing

10 tablets/strip

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Request QuotationWhatsApp
Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Agomelatine 25mg
Dosage Form
Tablet
Available Strengths
25mg
Packing
10 tablets/strip
Route of Administration
Oral, at bedtime
Dosage
25mg once daily at bedtime; may increase to 50mg daily after 2 weeks if insufficient response
Indications
Major depressive episodes in adults
Country of Origin
India (WHO-GMP Certified)
Storage
Store below 30°C, protect from light
Shelf Life
36 months
Side Effects
Headache, dizziness, nausea, diarrhea, somnolence, elevated transaminases, anxiety
Precautions
Liver function tests mandatory before initiation and periodically; contraindicated in hepatic impairment; avoid with strong CYP1A2 inhibitors (fluvoxamine); monitor ALT/AST at 3, 6, 12, and 24 weeks

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Escitalopram 10mgTablet

Escitalopram 10mg

Escitalopram Oxalate

Highly selective S-enantiomer of citalopram with superior serotonin reuptake inhibition and a cleaner off-target profile than the racemate, making it one of the best-tolerated and most prescribed SSRIs worldwide for both major depressive disorder and generalised anxiety disorder. Once-daily dosing, rapid onset (2–4 weeks), and predictable pharmacokinetics without clinically significant CYP interactions distinguish it from older SSRIs. Cipla and Sun Pharma manufacture 5mg, 10mg, and 20mg tablets exported globally for psychiatry and primary care markets.

5mg / 10mg / 20mg
Sertraline 100mgTablet

Sertraline 100mg

Sertraline Hydrochloride

SSRI with the broadest approved psychiatric indication set of any antidepressant — covering major depressive disorder, OCD, panic disorder, PTSD, social anxiety disorder, and premenstrual dysphoric disorder — making it the most versatile agent in its class for mental health export markets. Its favourable tolerability profile, low drug interaction potential, and availability in three strengths from 25mg to 100mg support flexible dosing for diverse patient populations. Cipla and Sun Pharma manufacture sertraline tablets exported to psychiatry and primary care markets globally.

25mg / 50mg / 100mg
Duloxetine 60mgCapsule

Duloxetine 60mg

Duloxetine Hydrochloride

Balanced serotonin-norepinephrine reuptake inhibitor with equal affinity for both transporters, addressing the emotional and physical symptom dimensions of depression and anxiety while providing independent analgesic benefit in diabetic peripheral neuropathy and fibromyalgia through descending pain pathway modulation. Its five distinct approved indications — MDD, GAD, DPNP, fibromyalgia, and chronic musculoskeletal pain — make it one of the most clinically versatile antidepressants available. Sun Pharma and Intas Pharmaceuticals manufacture 20mg, 30mg, and 60mg enteric-coated capsules exported globally.

20mg / 30mg / 60mg

Need bulk pricing for Agomelatine 25mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote